Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引：0
|
作者：
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构：
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16014
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
    Chen, Cong
    Zhang, Fan
    Zhou, Ning
    Gu, Yan-Mei
    Zhang, Ya-Ting
    He, Yi-Di
    Wang, Ling
    Yang, Lu-Xi
    Zhao, Yang
    Li, Yu-Min
    ONCOIMMUNOLOGY, 2019, 8 (05):
  • [32] Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
    Guven, Deniz Can
    Stephen, Bettzy
    Sahin, Taha Koray
    Cakir, Ibrahim Yahya
    Aksoy, Sercan
    LARYNGOSCOPE, 2024, 134 (01): : 7 - 17
  • [33] Immunotherapy and PARP inhibitors as first-line treatment in endometrial cancer: A systematic review and network meta-analysis
    Villacampa, Guillermo
    Eminowicz, Gemma
    Navarro, Victor
    Carita, Lorenzo
    Garcia-Illescas, David
    Oaknin, Ana
    Perez-Fidalgo, J. Alejandro
    EUROPEAN JOURNAL OF CANCER, 2025, 220
  • [34] Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer A network meta-analysis
    Zhang, Jingwen
    Huang, Yanhong
    Wang, Changyi
    He, Yuanfang
    Zheng, Shukai
    Wu, Kusheng
    MEDICINE, 2017, 96 (33)
  • [35] Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis
    Li, Lixi
    Wu, Yun
    Lan, Bo
    Ma, Fei
    CANCER INNOVATION, 2024, 3 (04):
  • [36] Comparative efficacy and tolerability of first-line treatments for untreated, HER2-negative, advanced gastric cancer: systematic review and network meta-analysis
    Cai, Tongze
    Liang, Liuguan
    Zhao, Xingxing
    Lin, Caiyue
    Li, Dandan
    Zheng, Jinghui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 193
  • [37] Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review
    Zou, Kun
    Yang, Shuailong
    Zheng, Liang
    Yang, Chaogang
    Xiong, Bin
    BMC CANCER, 2016, 16
  • [38] Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis
    Sun, Jinping
    Ren, Zheng
    Sun, Xinfang
    Hou, Hongtao
    Li, Ke
    Ge, Quanxing
    ONCOTARGET, 2017, 8 (24) : 39673 - 39682
  • [39] Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review
    Kun Zou
    Shuailong Yang
    Liang Zheng
    Chaogang Yang
    Bin Xiong
    BMC Cancer, 16
  • [40] Systematic or Meta-analysis Studies Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis
    Martini, Alberto
    Raggi, Daniele
    Fallara, Giuseppe
    Nocera, Luigi
    Schultz, Julianne G.
    Belladelli, Federico
    Marandino, Laura
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Powles, Thomas
    Necchi, Andrea
    CANCER TREATMENT REVIEWS, 2022, 104
12345